What was the impetus for regulating biotechnology while other methods of genetic modification remain exempted from premarket safety assessments? How were the regulations made? How are they enforced? How do the diverse political agendas meld with the scientific foundation in assessing safety? How does the perspective of the technology developer differ from that of the biosafety regulator? In addressing these questions and others, this book offers authoritative and comprehensive yet accessible and illuminating insights into the agricultural biotech regulatory systems in both countries.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.